Actinium has received some more interest since my last article on October 15th, and has continued to put out impressive data, which combined with the recent offer by Bayer for $2.4 billion on Algeta ASA , the other alpha emitter cancer therapy company, on November 26th, likely indicates the company has compelling prospects ahead.
http://seekingalpha.com/article/1873981-actinium-scarcity-value-after-bayer-takeout-of-closest-peer?source=feed
http://seekingalpha.com/article/1873981-actinium-scarcity-value-after-bayer-takeout-of-closest-peer?source=feed
No comments:
Post a Comment